Correction: Application of next-generation imaging in biochemically recurrent prostate cancer.

Moul, Judd W; Shore, Neal D; Pienta, Kenneth J; Czernin, Johannes; King, Martin T; Freedland, Stephen J

Moul, Judd W; Shore, Neal D; Pienta, Kenneth J; Czernin, Johannes; King, Martin T; Freedland, Stephen J.

Afiliación

Moul JW; Duke Cancer Institute and Division of Urology, Duke University, Durham, NC, USA.
Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
Pienta KJ; Johns Hopkins School of Medicine, Baltimore, MD, USA.
Czernin J; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
King MT; Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.
Freedland SJ; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Stephen.Freedland@cshs.org.

Prostate Cancer Prostatic Dis ; 27(2): 358, 2024 Jun.

Article en En | MEDLINE | ID: mdl-38233472

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Prostate Cancer Prostatic Dis Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google